Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A E Veroff

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
The Annals of Pharmacotherapy|December 1, 1996
Efficacy and safety of BMY 21,502 in Alzheimer diseaseR C Shrotriya, N R Cutler, J J Sramek, et al.
Journal of Clinical Pharmacology|May 1, 1993
Psychomotor and memory effects of two adinazolam formulations assessed by a computerized neuropsychological test batteryJ C Fleishaker, T A Sisson, J J Sramek, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|October 1, 1996
Assessing the neuropsychological profile of stable schizophrenic outpatientsN R Cutler, A E Veroff, E J Frackiewicz, et al.
Journal of Geriatric Psychiatry and Neurology|October 1, 1991
A new assessment tool for neuropsychopharmacologic research: the Computerized Neuropsychological Test BatteryA E Veroff, N R Cutler, J J Sramek, et al.
Alzheimer Disease and Associated Disorders|January 1, 1993
A pilot clinical trial of the angiotensin-converting enzyme inhibitor ceranapril in Alzheimer diseaseA Sudilovsky, N R Cutler, J J Sramek, et al.
Annals of the New York Academy of Sciences|September 24, 1993
The use of the Computerized Neuropsychological Test Battery (CNTB) in an efficacy and safety trial of BMY 21,502 in Alzheimer's diseaseN R Cutler, R C Shrotriya, J J Sramek, et al.
Journal of Clinical Psychopharmacology|February 1, 1995
Effects of the cholinomimetic SDZ ENS-163 on scopolamine-induced cognitive impairment in humansE P Brass, R Polinsky, J J Sramek, et al.
The American Journal of Psychiatry|February 1, 1984
Clinical correlates of lateral ventricular enlargement in bipolar affective disorderG D Pearlson, D J Garbacz, R H Tompkins, et al.
The Journal of Prevention of Alzheimer'S Disease|May 11, 2022
Sensitivity of the Preclinical Alzheimer's Cognitive Composite (PACC), PACC5, and Repeatable Battery for Neuropsychological Status (RBANS) to Amyloid Status in Preclinical Alzheimer's Disease -Atabecestat Phase 2b/3 EARLY Clinical TrialK V Papp, H Rofael, A E Veroff, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
The Annals of Pharmacotherapy|December 1, 1996
Efficacy and safety of BMY 21,502 in Alzheimer diseaseR C Shrotriya, N R Cutler, J J Sramek, et al.
Journal of Clinical Pharmacology|May 1, 1993
Psychomotor and memory effects of two adinazolam formulations assessed by a computerized neuropsychological test batteryJ C Fleishaker, T A Sisson, J J Sramek, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|October 1, 1996
Assessing the neuropsychological profile of stable schizophrenic outpatientsN R Cutler, A E Veroff, E J Frackiewicz, et al.
Journal of Geriatric Psychiatry and Neurology|October 1, 1991
A new assessment tool for neuropsychopharmacologic research: the Computerized Neuropsychological Test BatteryA E Veroff, N R Cutler, J J Sramek, et al.
Alzheimer Disease and Associated Disorders|January 1, 1993
A pilot clinical trial of the angiotensin-converting enzyme inhibitor ceranapril in Alzheimer diseaseA Sudilovsky, N R Cutler, J J Sramek, et al.
Annals of the New York Academy of Sciences|September 24, 1993
The use of the Computerized Neuropsychological Test Battery (CNTB) in an efficacy and safety trial of BMY 21,502 in Alzheimer's diseaseN R Cutler, R C Shrotriya, J J Sramek, et al.
Journal of Clinical Psychopharmacology|February 1, 1995
Effects of the cholinomimetic SDZ ENS-163 on scopolamine-induced cognitive impairment in humansE P Brass, R Polinsky, J J Sramek, et al.
The American Journal of Psychiatry|February 1, 1984
Clinical correlates of lateral ventricular enlargement in bipolar affective disorderG D Pearlson, D J Garbacz, R H Tompkins, et al.
The Journal of Prevention of Alzheimer'S Disease|May 11, 2022
Sensitivity of the Preclinical Alzheimer's Cognitive Composite (PACC), PACC5, and Repeatable Battery for Neuropsychological Status (RBANS) to Amyloid Status in Preclinical Alzheimer's Disease -Atabecestat Phase 2b/3 EARLY Clinical TrialK V Papp, H Rofael, A E Veroff, et al.
Pageof 2